Abbonarsi

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients - 01/12/17

Doi : 10.1016/j.clinre.2017.05.003 
Astrid Marot a, Aïmen Belaid b, Hans Orlent c, Thomas Sersté d, Peter Michielsen e, Isabelle Colle f, Wim Laleman g, Chantal de Galocsy h, Hendrik Reynaert i, François D’Heygere j, Christophe Moreno k, Christopher Doerig a, Jean Henrion b, Pierre Deltenre a, k,
a Division of Gastroenterology and Hepatology, centre hospitalier universitaire vaudois, University of Lausanne, rue du Bugnon, 44, 1011 Lausanne, Switzerland 
b Department of Gastroenterology and Hepatology, hôpital de Jolimont, 7100 Haine-Saint-Paul, Belgium 
c Department of Gastroenterology and Hepatology, AZ St Jan, 8000 Brugge, Belgium 
d Department of Gastroenterology and Hepatology, CHU Saint-Pierre, 1000 Brussels, Belgium 
e Department of Gastroenterology and Hepatology, UZ Antwerpen, 2650 Edegem, Belgium 
f Department of Gastroenterology and Hepatology, Ghent University Hospital, 9000 Ghent, Belgium 
g Department of Gastroenterology and Hepatology, KUL, 3000 Leuven, Belgium 
h Department of Gastroenterology and Hepatology, hôpitaux Iris Sud Bracops, 1070 Brussels, Belgium 
i Department of Gastroenterology and Hepatology, UZ Brussel, 1090 Brussels, Belgium 
j Department of Gastroenterology and Hepatology, AZ Groeninge, 8510 Kortrijk, Belgium 
k Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB hôpital Erasme, université Libre de Bruxelles, 1070 Brussels, Belgium 

Corresponding author. Division of Gastroenterology and Hepatology, centre hospitalier universitaire vaudois, University of Lausanne, rue du Bugnon, 44, 1011 Lausanne, Switzerland.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 8
Iconografia 0
Video 0
Altro 0

Highlights

Updated data on dual HBV and HCV infection are needed. Patients with dual infection were more often immigrants from endemic area, which should guide strategies for cases identification. Dual-infected patients had similar fibrosis stages than HCV or HBV mono-infected patients.

Il testo completo di questo articolo è disponibile in PDF.

Summary

The epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections is continuously evolving. Updated data on dual HBV and HCV infection are still needed.

Aims

To assess the main characteristics of patients with HBV and HCV dual infection, to compare these with those of patients infected with either HBV or HCV and, among patients with dual infection, to assess fibrosis according to HCV replication.

Methods

Data of 23 patients with dual infection were compared to data from 92 age and sex-matched HBV or HCV monoinfected patients.

Results

Patients with dual infection were more often immigrants from Africa or Asia than HCV or HBV patients (52% vs. 20% and 22%, respectively, P=0.01). Intravenous drug use was the route of transmission in 22% of patients with dual infection, which was less frequent than in HCV patients (41%) but more frequent than in HBV patients (0%). Extensive fibrosis or cirrhosis was as frequent among dual-infected patients as among those with HCV or chronic hepatitis B infection (19% vs. 29% vs. 14%, respectively, P=0.4), even when fibrosis stage was reported considering the duration of infection. In dual-infected patients, the prevalence of extensive fibrosis or cirrhosis was similar in patients with and without detectable HCV RNA (18% vs. 20%).

Conclusions

Patients with HBV and HCV dual infection were more often immigrants from Africa or Asia and had similar fibrosis stages than HCV or HBV monoinfected patients. In patients with dual infection, extensive fibrosis or cirrhosis was not associated with HCV replication.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Epidemiology, Screening, Viral hepatitis

Abbreviations : Ag, ALT, BASL, CI, HBV, HCC, HCV, HBsAg, NA, SDs


Mappa


© 2017  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 41 - N° 6

P. 656-663 - Dicembre 2017 Ritorno al numero
Articolo precedente Articolo precedente
  • Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-?)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection
  • Claudia Mascia, Miriam Lichtner, Paola Zuccalà, Serena Vita, Tiziana Tieghi, Raffaella Marocco, Stefano Savinelli, Raffaella Rossi, Marco Iannetta, Michela Campagna, Francesco Schiavone, Fabio Mengoni, Gianluca Russo, Claudio Maria Mastroianni, Vincenzo Vullo
| Articolo seguente Articolo seguente
  • Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: An updated meta-analysis
  • Lei Zheng, Chunbo Zhuang, Junwei Zhao, Liang Ming

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.